nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—Lower respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.0332	0.0609	CcSEcCtD
Bosentan—Liver injury—Ramipril—type 1 diabetes mellitus	0.0135	0.0247	CcSEcCtD
Bosentan—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.0131	0.024	CcSEcCtD
Bosentan—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.0093	0.017	CcSEcCtD
Bosentan—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00917	0.0168	CcSEcCtD
Bosentan—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00905	0.0166	CcSEcCtD
Bosentan—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.0087	0.0159	CcSEcCtD
Bosentan—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00866	0.0159	CcSEcCtD
Bosentan—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00844	0.0155	CcSEcCtD
Bosentan—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00844	0.0155	CcSEcCtD
Bosentan—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00841	0.0154	CcSEcCtD
Bosentan—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00827	0.0152	CcSEcCtD
Bosentan—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00818	0.015	CcSEcCtD
Bosentan—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00761	0.0139	CcSEcCtD
Bosentan—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00753	0.0138	CcSEcCtD
Bosentan—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00753	0.0138	CcSEcCtD
Bosentan—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00742	0.0136	CcSEcCtD
Bosentan—Asthma—Ramipril—type 1 diabetes mellitus	0.00712	0.013	CcSEcCtD
Bosentan—Influenza—Ramipril—type 1 diabetes mellitus	0.00712	0.013	CcSEcCtD
Bosentan—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00705	0.0129	CcSEcCtD
Bosentan—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00701	0.0128	CcSEcCtD
Bosentan—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00694	0.0127	CcSEcCtD
Bosentan—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00694	0.0127	CcSEcCtD
Bosentan—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00685	0.0125	CcSEcCtD
Bosentan—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00666	0.0122	CcSEcCtD
Bosentan—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00662	0.0121	CcSEcCtD
Bosentan—Weight increased—Ramipril—type 1 diabetes mellitus	0.00648	0.0119	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.0063	0.0115	CcSEcCtD
Bosentan—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00626	0.0115	CcSEcCtD
Bosentan—Renal failure—Ramipril—type 1 diabetes mellitus	0.00624	0.0114	CcSEcCtD
Bosentan—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00623	0.0114	CcSEcCtD
Bosentan—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00619	0.0113	CcSEcCtD
Bosentan—Jaundice—Ramipril—type 1 diabetes mellitus	0.00619	0.0113	CcSEcCtD
Bosentan—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00617	0.0113	CcSEcCtD
Bosentan—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00617	0.0113	CcSEcCtD
Bosentan—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00601	0.011	CcSEcCtD
Bosentan—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00599	0.011	CcSEcCtD
Bosentan—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00596	0.0109	CcSEcCtD
Bosentan—Hepatitis—Ramipril—type 1 diabetes mellitus	0.0057	0.0104	CcSEcCtD
Bosentan—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00562	0.0103	CcSEcCtD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL20—type 1 diabetes mellitus	0.0056	0.0123	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL11—type 1 diabetes mellitus	0.0056	0.0123	CbGpPWpGaD
Bosentan—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00539	0.00987	CcSEcCtD
Bosentan—EDNRB—Peptide GPCRs—CCR5—type 1 diabetes mellitus	0.00532	0.0117	CbGpPWpGaD
Bosentan—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00532	0.00973	CcSEcCtD
Bosentan—Flushing—Ramipril—type 1 diabetes mellitus	0.00529	0.00969	CcSEcCtD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.0052	0.0115	CbGpPWpGaD
Bosentan—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00515	0.00943	CcSEcCtD
Bosentan—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00514	0.00941	CcSEcCtD
Bosentan—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00499	0.00915	CcSEcCtD
Bosentan—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00496	0.00909	CcSEcCtD
Bosentan—Erythema—Ramipril—type 1 diabetes mellitus	0.00496	0.00909	CcSEcCtD
Bosentan—EDNRA—Endothelin Pathways—NOS3—type 1 diabetes mellitus	0.00495	0.0109	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—ITPR3—type 1 diabetes mellitus	0.00479	0.0106	CbGpPWpGaD
Bosentan—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00477	0.00874	CcSEcCtD
Bosentan—Tremor—Ramipril—type 1 diabetes mellitus	0.00465	0.00851	CcSEcCtD
Bosentan—Angioedema—Ramipril—type 1 diabetes mellitus	0.00453	0.0083	CcSEcCtD
Bosentan—Vertigo—Ramipril—type 1 diabetes mellitus	0.00446	0.00816	CcSEcCtD
Bosentan—Syncope—Ramipril—type 1 diabetes mellitus	0.00445	0.00815	CcSEcCtD
Bosentan—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00444	0.00813	CcSEcCtD
Bosentan—Palpitations—Ramipril—type 1 diabetes mellitus	0.00439	0.00803	CcSEcCtD
Bosentan—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00436	0.00799	CcSEcCtD
Bosentan—Cough—Ramipril—type 1 diabetes mellitus	0.00433	0.00793	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.00429	0.00944	CbGpPWpGaD
Bosentan—Chest pain—Ramipril—type 1 diabetes mellitus	0.00423	0.00774	CcSEcCtD
Bosentan—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00423	0.00774	CcSEcCtD
Bosentan—Anxiety—Ramipril—type 1 diabetes mellitus	0.00421	0.00771	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.0042	0.00768	CcSEcCtD
Bosentan—Discomfort—Ramipril—type 1 diabetes mellitus	0.00417	0.00764	CcSEcCtD
Bosentan—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00413	0.00757	CcSEcCtD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.00413	0.00909	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—GAL—type 1 diabetes mellitus	0.00406	0.00894	CbGpPWpGaD
Bosentan—Oedema—Ramipril—type 1 diabetes mellitus	0.00405	0.00742	CcSEcCtD
Bosentan—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00405	0.00742	CcSEcCtD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL11—type 1 diabetes mellitus	0.00401	0.00884	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL20—type 1 diabetes mellitus	0.00401	0.00884	CbGpPWpGaD
Bosentan—Shock—Ramipril—type 1 diabetes mellitus	0.00399	0.0073	CcSEcCtD
Bosentan—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00397	0.00727	CcSEcCtD
Bosentan—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00397	0.00726	CcSEcCtD
Bosentan—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00395	0.00724	CcSEcCtD
Bosentan—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00393	0.0072	CcSEcCtD
Bosentan—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00392	0.00717	CcSEcCtD
Bosentan—EDNRB—Peptide ligand-binding receptors—SST—type 1 diabetes mellitus	0.00388	0.00856	CbGpPWpGaD
Bosentan—Anorexia—Ramipril—type 1 diabetes mellitus	0.00386	0.00707	CcSEcCtD
Bosentan—EDNRA—Peptide GPCRs—CCR5—type 1 diabetes mellitus	0.00381	0.00839	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.0038	0.00838	CbGpPWpGaD
Bosentan—Hypotension—Ramipril—type 1 diabetes mellitus	0.00378	0.00693	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00376	0.00828	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00376	0.00828	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00369	0.00676	CcSEcCtD
Bosentan—Insomnia—Ramipril—type 1 diabetes mellitus	0.00366	0.00671	CcSEcCtD
Bosentan—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00364	0.00666	CcSEcCtD
Bosentan—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00361	0.00661	CcSEcCtD
Bosentan—Somnolence—Ramipril—type 1 diabetes mellitus	0.0036	0.00659	CcSEcCtD
Bosentan—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00357	0.00653	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00353	0.00779	CbGpPWpGaD
Bosentan—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00352	0.00645	CcSEcCtD
Bosentan—EDNRB—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.00351	0.00773	CbGpPWpGaD
Bosentan—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.0035	0.0064	CcSEcCtD
Bosentan—Fatigue—Ramipril—type 1 diabetes mellitus	0.00349	0.00639	CcSEcCtD
Bosentan—Constipation—Ramipril—type 1 diabetes mellitus	0.00346	0.00634	CcSEcCtD
Bosentan—EDNRA—G alpha (q) signalling events—ITPR3—type 1 diabetes mellitus	0.00343	0.00756	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.00338	0.00744	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00331	0.00606	CcSEcCtD
Bosentan—EDNRA—GPCRs, Other—CCR5—type 1 diabetes mellitus	0.00323	0.00711	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00323	0.00711	CbGpPWpGaD
Bosentan—Urticaria—Ramipril—type 1 diabetes mellitus	0.00322	0.00589	CcSEcCtD
Bosentan—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.0032	0.00586	CcSEcCtD
Bosentan—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.0032	0.00586	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.00314	0.00691	CbGpPWpGaD
Bosentan—ABCB11—Bile acid and bile salt metabolism—ALB—type 1 diabetes mellitus	0.00311	0.00686	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.00307	0.00676	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00303	0.00667	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.00302	0.00665	CbGpPWpGaD
Bosentan—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00298	0.00546	CcSEcCtD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.00295	0.00651	CbGpPWpGaD
Bosentan—Asthenia—Ramipril—type 1 diabetes mellitus	0.00291	0.00532	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.0029	0.00638	CbGpPWpGaD
Bosentan—Pruritus—Ramipril—type 1 diabetes mellitus	0.00287	0.00525	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00286	0.00631	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00286	0.00631	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—SST—type 1 diabetes mellitus	0.00278	0.00613	CbGpPWpGaD
Bosentan—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00277	0.00507	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00272	0.006	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00269	0.00593	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00269	0.00593	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00269	0.00593	CbGpPWpGaD
Bosentan—Dizziness—Ramipril—type 1 diabetes mellitus	0.00268	0.0049	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00261	0.00574	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00259	0.00572	CbGpPWpGaD
Bosentan—Vomiting—Ramipril—type 1 diabetes mellitus	0.00258	0.00472	CcSEcCtD
Bosentan—Rash—Ramipril—type 1 diabetes mellitus	0.00255	0.00468	CcSEcCtD
Bosentan—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00255	0.00467	CcSEcCtD
Bosentan—Headache—Ramipril—type 1 diabetes mellitus	0.00254	0.00465	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00253	0.00557	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.00251	0.00553	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.0025	0.00552	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.00242	0.00532	CbGpPWpGaD
Bosentan—Nausea—Ramipril—type 1 diabetes mellitus	0.00241	0.00441	CcSEcCtD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00231	0.00509	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00226	0.00498	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.00224	0.00495	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00217	0.00477	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00217	0.00477	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.00216	0.00476	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00207	0.00457	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00205	0.00451	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00205	0.00451	CbGpPWpGaD
Bosentan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00199	0.00439	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00198	0.00437	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00198	0.00435	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00196	0.00432	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00193	0.00424	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00187	0.00411	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00186	0.00409	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00179	0.00395	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00177	0.0039	CbGpPWpGaD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00174	0.00382	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00168	0.0037	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00165	0.00363	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00164	0.0036	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00162	0.00356	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00162	0.00356	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.00157	0.00347	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00155	0.00341	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00152	0.00335	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00149	0.00327	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00147	0.00324	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00147	0.00324	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00142	0.00313	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00141	0.00312	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.0014	0.00309	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00138	0.00304	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00137	0.00301	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00128	0.00282	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00128	0.00281	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00127	0.00279	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00124	0.00273	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.0012	0.00265	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00118	0.0026	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00117	0.00258	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00116	0.00256	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00116	0.00255	CbGpPWpGaD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00114	0.00252	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.00113	0.00248	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00112	0.00247	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00112	0.00246	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00109	0.0024	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00106	0.00234	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00105	0.00232	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00105	0.00232	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00102	0.00224	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00101	0.00223	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.001	0.00221	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.001	0.0022	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000989	0.00218	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000977	0.00215	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000962	0.00212	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000934	0.00206	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000932	0.00205	CbGpPWpGaD
Bosentan—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000926	0.00204	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000915	0.00202	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000914	0.00201	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000908	0.002	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000888	0.00196	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000878	0.00193	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000874	0.00193	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000868	0.00191	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000868	0.00191	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000849	0.00187	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000849	0.00187	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000846	0.00186	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00083	0.00183	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000816	0.0018	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000803	0.00177	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000799	0.00176	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.00077	0.0017	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HBA2—type 1 diabetes mellitus	0.000743	0.00164	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000733	0.00161	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000729	0.00161	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000726	0.0016	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000725	0.0016	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000723	0.00159	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000717	0.00158	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000715	0.00158	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000712	0.00157	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—G6PC2—type 1 diabetes mellitus	0.000698	0.00154	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000689	0.00152	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000689	0.00152	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000685	0.00151	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000685	0.00151	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000669	0.00147	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000667	0.00147	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000656	0.00145	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00065	0.00143	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000647	0.00142	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000628	0.00138	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000625	0.00138	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000621	0.00137	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000621	0.00137	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000607	0.00134	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000606	0.00133	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ABCC8—type 1 diabetes mellitus	0.000606	0.00133	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SST—type 1 diabetes mellitus	0.000602	0.00133	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000599	0.00132	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000584	0.00129	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000551	0.00121	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000536	0.00118	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000524	0.00116	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000517	0.00114	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000516	0.00114	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00051	0.00112	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000501	0.0011	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.0005	0.0011	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000493	0.00109	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00049	0.00108	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00049	0.00108	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000479	0.00105	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000478	0.00105	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00047	0.00103	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000463	0.00102	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000456	0.001	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000454	0.001	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000437	0.000963	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SST—type 1 diabetes mellitus	0.000431	0.000949	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000429	0.000944	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000418	0.00092	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000415	0.000914	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ITPR3—type 1 diabetes mellitus	0.000404	0.00089	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000394	0.000868	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000388	0.000854	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000384	0.000846	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000382	0.000842	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HBA1—type 1 diabetes mellitus	0.00038	0.000838	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000379	0.000835	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOC3—type 1 diabetes mellitus	0.000378	0.000833	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTT1—type 1 diabetes mellitus	0.000371	0.000818	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000369	0.000814	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000359	0.00079	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000358	0.000788	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000342	0.000754	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000326	0.000719	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000325	0.000716	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000319	0.000703	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000313	0.000689	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—INS—type 1 diabetes mellitus	0.000301	0.000664	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000299	0.000658	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000297	0.000654	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GCG—type 1 diabetes mellitus	0.000296	0.000652	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000291	0.000642	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.00029	0.000639	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000283	0.000624	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000282	0.000622	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000277	0.000611	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000273	0.000602	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000271	0.000598	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000269	0.000593	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000264	0.000582	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CAT—type 1 diabetes mellitus	0.00025	0.000552	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	0.000248	0.000546	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	0.000233	0.000514	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000228	0.000503	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000224	0.000494	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000224	0.000493	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000223	0.000491	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—INS—type 1 diabetes mellitus	0.000216	0.000475	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000209	0.00046	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000208	0.000457	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	0.000202	0.000445	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000193	0.000424	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000189	0.000417	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000188	0.000415	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000171	0.000377	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—INS—type 1 diabetes mellitus	0.000166	0.000366	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.000164	0.00036	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000161	0.000354	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2—type 1 diabetes mellitus	0.00016	0.000353	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00016	0.000352	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.00016	0.000351	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.000154	0.000339	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—type 1 diabetes mellitus	0.000152	0.000336	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NOS3—type 1 diabetes mellitus	0.000146	0.000321	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	0.000135	0.000297	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000135	0.000297	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	0.000133	0.000294	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000132	0.00029	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	0.000127	0.00028	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	0.000126	0.000278	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	0.000124	0.000273	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000123	0.00027	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000114	0.000252	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000105	0.000232	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	9.87e-05	0.000218	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—type 1 diabetes mellitus	9.42e-05	0.000208	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	8.9e-05	0.000196	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	8.37e-05	0.000184	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	8.36e-05	0.000184	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	8.32e-05	0.000183	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	8.17e-05	0.00018	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	6.51e-05	0.000143	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	5.55e-05	0.000122	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	5.51e-05	0.000121	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	5.09e-05	0.000112	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	4.87e-05	0.000107	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	3.66e-05	8.06e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	3.35e-05	7.39e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	3.21e-05	7.07e-05	CbGpPWpGaD
